Loading company
vTv Therapeutics Inc. (VTVT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $1 million | -100% | 10-K 2026-03-10 · proof |
| Operating income | -$32.8 million | -$24.2 million | 10-K 2026-03-10 · proof | |
| Net income | -$27 million | -$18.5 million | 10-K 2026-03-10 · proof | |
| Cash from operating activities | -$25.3 million | -$25.3 million | 10-K 2026-03-10 · proof | |
| Total assets | $89.9 million | $38.3 million | +134.9% | 10-K 2026-03-10 · proof |
| Total liabilities | $25.5 million | $24 million | +6.2% | 10-K 2026-03-10 · proof |
| Cash and cash equivalents | $88.9 million | $36.7 million | +142% | 10-K 2026-03-10 · proof |
- What was vTv Therapeutics Inc. (VTVT)'s revenue in fiscal 2025?
- vTv Therapeutics Inc. (VTVT) reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $1 million the year before (-100%). Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was vTv Therapeutics Inc. (VTVT)'s operating income in fiscal 2025?
- vTv Therapeutics Inc. (VTVT) reported operating income of -$32.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$24.2 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was vTv Therapeutics Inc. (VTVT)'s net income in fiscal 2025?
- vTv Therapeutics Inc. (VTVT) reported net income of -$27 million for fiscal 2025 (the year ended Dec 31, 2025), against -$18.5 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was vTv Therapeutics Inc. (VTVT)'s cash from operating activities in fiscal 2025?
- vTv Therapeutics Inc. (VTVT) reported cash from operating activities of -$25.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$25.3 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What are vTv Therapeutics Inc. (VTVT)'s total assets?
- As of Dec 31, 2025, vTv Therapeutics Inc. (VTVT) reported total assets of $89.9 million, against $38.3 million a year earlier (+134.9%). Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What are vTv Therapeutics Inc. (VTVT)'s total liabilities?
- As of Dec 31, 2025, vTv Therapeutics Inc. (VTVT) reported total liabilities of $25.5 million, against $24 million a year earlier (+6.2%). Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What are vTv Therapeutics Inc. (VTVT)'s cash and cash equivalents?
- As of Dec 31, 2025, vTv Therapeutics Inc. (VTVT) reported cash and cash equivalents of $88.9 million, against $36.7 million a year earlier (+142%). Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:VTVT&period_type=annual&limit=5"Information only, not investment advice.